The OS used in this study are from pooled human milk provided by milk banks in San Jose, CA and Austin, TX. HMOs were isolated from the milk using a previously described procedure involving defatting, chloroform/methanol extraction, ethanol precipitation, and evaporation.6 (link) A sample enrichment step with solid phase extraction (SPE) employing graphitized carbon cartridge (GCC) was used before the analysis. GCC (150 mg bed weight, 4mL volume) were purchased from Alltech (Deerfield, IL). Sodium borohydride (98%) and 2, 5-dihydroxybenzoic acid (DHB) were obtained from Sigma–Aldrich (St. Louis, MO). Standard HMOs were purchased from Dextra Laboratories (Earley Gate, UK). α(1–2)-Fucosidase was obtained from EMD CALBIOCHEM (La Jolla, CA), β(1–3)-galactosidase and α(2–3)-neuraminidase from New England Biolab (Beverly, MA), β(1–4)-galactosidase from ProZyme (San Leandro, CA), and α(1–3,4)-fucosidase from Sigma–Aldrich (St. Louis, MO). The non-selective sialidase was purified and provided by Prof. David Mills from the Department of Viticulture and Enology in UC Davis. All reagents are of analytical or HPLC grade.